亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

(R)-2-(2,5-二氟苯基)吡咯烷***

 
 
單價 100.00 / 公斤對比
銷量 暫無
發貨 山東濟南市付款后3天內
庫存 1000公斤起訂1公斤
品牌 濟南溫莎
中文名稱 (R)-2-(2,5-二氟苯基)吡咯烷鹽酸鹽
CAS 1218935-60-4
外觀 白色粉末
過期 長期有效
更新 2020-06-22 11:20
 

濟南溫莎醫藥科技有限公司

企業會員第10年
資料未認證
保證金未繳納
詳細說明

中文名稱:(R)-2-(2,5-二氟苯基)吡咯烷***

CAS號:1218935-60-4英文名稱:(R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINEHYDROCHLORIDE

英文同義詞:(R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINEHCL;(R)-2-(2,5-Difluorophenyl)pyrrolidenehydroChemicalbookchloride;(R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDINEHYDROCHLORIDE中文名稱:(R)-2-(2,5-二氟苯基)吡咯烷***

中文同義詞:(R)-2-(2,5-二氟苯基)吡咯烷***

CBNumber:CB4816500

分子式:C10H12ClF2N

分子量:219.6587864

外觀:白色粉末

純度:99%,

舉報收藏 0評論 0
更多>本企業其它產品
濟南溫莎***柔紅霉素/***佐柔比星23541-50-6廠家 溫莎醫藥***多柔比星25316-40-9廠家 濟南***表阿霉素/***表柔比星56390-09-1 溫莎醫藥 米格列醇 72432-03-2 廠家 濟南溫莎克拉維酸鉀:微晶纖維素 1:1 61177-45-5 濟南阿莫西林:克拉維酸鉀 4:1  61177-45-5廠家 濟南溫莎克拉維酸鉀:微晶纖維素 1:1 61177-45-5 溫莎6乙酰氧基4氯7甲氧基喹唑啉230955-75-6
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |